Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
6,140.00
-150.00 (-2.38%)
At close: Oct 23, 2026
| Market Cap | 69.85B +2.3% |
| Revenue (ttm) | 86.82B +7.2% |
| Net Income | 6.42B -44.1% |
| EPS | 555.26 -44.1% |
| Shares Out | 11.38M |
| PE Ratio | 11.06 |
| Forward PE | n/a |
| Dividend | 190.00 (3.09%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 12,047 |
| Open | 6,330.00 |
| Previous Close | 6,290.00 |
| Day's Range | 5,980.00 - 6,330.00 |
| 52-Week Range | 4,820.00 - 6,820.00 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |